Hepatic uptake of epirubicin by isolated rat hepatocytes and its biliary excretion after intravenous infusion in rats
暂无分享,去创建一个
[1] Chun-Woong Park,et al. Validation of high-performance liqid chromatography method to determine epirubicin and its pharmacokinetics after intravenous bolus administration in rats , 2013, Journal of Pharmaceutical Investigation.
[2] K. Arimori,et al. Inhibition of carrier‐mediated uptake of epirubicin reduces cytotoxicity in primary culture of rat hepatocytes , 2008, Journal of applied toxicology : JAT.
[3] K. Arimori,et al. Effect of acute hepatic failure on epirubicin pharmacokinetics after intrahepatic arterial injection in rats. , 2008, Biological & pharmaceutical bulletin.
[4] Xuyang Peng,et al. The cardiotoxicology of anthracycline chemotherapeutics: translating molecular mechanism into preventative medicine. , 2005, Molecular interventions.
[5] Sukgil Song,et al. HPLC analysis and pharmacokinetic characteristics of 11-hydroxyaclacinomycin X (ID-6105), a novel anthracycline, in rats and beagle dogs. , 2005, Biological & pharmaceutical bulletin.
[6] J. Hanfelt,et al. Epirubicin cardiotoxicity: A study comparing low- with high-dose-intensity weekly schedules , 1996, Supportive Care in Cancer.
[7] L. Gianni,et al. Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity , 2004, Pharmacological Reviews.
[8] Y. Sugiyama,et al. Recent Advances in Carrier-mediated Hepatic Uptake and Biliary Excretion of Xenobiotics , 1996, Pharmaceutical Research.
[9] Y. Lo,et al. Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[10] Federico Innocenti,et al. Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients. , 2002, British journal of clinical pharmacology.
[11] Y. Lo,et al. Phospholipids as multidrug resistance modulators of the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats. , 2000, Biochemical pharmacology.
[12] J. Zalcberg,et al. Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line , 1999, British Journal of Cancer.
[13] K. Chihara,et al. Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells , 1996, Cancer Chemotherapy and Pharmacology.
[14] Y. Sugiyama,et al. Na(+)-independent multispecific anion transporter mediates active transport of pravastatin into rat liver. , 1993, The American journal of physiology.
[15] J. Robert. Epirubicin. Clinical pharmacology and dose-effect relationship. , 1993, Drugs.
[16] T. Iga,et al. Uptake of organic anions by isolated rat hepatocytes. A classification in terms of ATP-dependency. , 1992, Journal of hepatology.
[17] H. Fujita,et al. Pharmacokinetics of doxorubicin, (2"R)-4'-O-tetrahydropyranyl-adriamycin and aclarubicin. , 1986, The Japanese journal of antibiotics.
[18] T. Oki,et al. [Studies on the absorption, excretion and distribution of aclacinomycin A: absorption, excretion and distribution of 14C- or 3H-aclacinomycin A in mice, rats and rabbits (author's transl)]. , 1980, The Japanese journal of antibiotics.
[19] D. Eaton,et al. Uptake of unconjugated bilirubin by isolated rat hepatocytes. , 1979, The American journal of physiology.